GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis

  1. Ricardo A Cordova
  2. Jagannath Misra
  3. Parth H Amin
  4. Anglea J Klunk
  5. Nur P Damayanti
  6. Kenneth R Carlson
  7. Andrew J Elmendorf
  8. Hyeong-Geug Kim
  9. Emily T Mirek
  10. Bennet D Elzey
  11. Marcus J Miller
  12. X Charlie Dong
  13. Liang Cheng
  14. Tracy G Anthony
  15. Robero Pili  Is a corresponding author
  16. Ronald C Wek  Is a corresponding author
  17. Kirk A Staschke  Is a corresponding author
  1. Indiana University, United States
  2. Rutgers, The State University of New Jersey, United States
  3. Purdue University West Lafayette, United States
  4. Indiana University School of Medicine, United States
  5. University at Buffalo, State University of New York, United States

Abstract

A stress adaptation pathway termed the integrated stress response has been suggested to be active in many cancers including prostate cancer (PCa). Here, we demonstrate that the eIF2 kinase GCN2 is required for sustained growth in androgen-sensitive and castration-resistant models of PCa both in vitro and in vivo, and is active in PCa patient samples. Using RNA-seq transcriptome analysis and a CRISPR-based phenotypic screen, GCN2 was shown to regulate expression of over 60 solute-carrier (SLC) genes, including those involved in amino acid transport and loss of GCN2 function reduces amino acid import and levels. Addition of essential amino acids or expression of 4F2 (SLC3A2) partially restored growth following loss of GCN2, suggesting that GCN2 targeting of SLC transporters is required for amino acid homeostasis needed to sustain tumor growth. A small molecule inhibitor of GCN2 showed robust in vivo efficacy in androgen-sensitive and castration-resistant mouse models of PCa, supporting its therapeutic potential for the treatment of PCa.

Data availability

The authors declare that all data generated or analyzed in this study are included in the published article, its supplementary information and source files, or are publicly available. The CHARGE-seq and RNA-seq datasets generated in this study have been deposited in the NCBI Gene Expression Omnibus (GEO) database under the ascension codes GSE196251 and GSE196252, respectively. The custom python script used in the analysis of our Charge-seq study is available on GitHub (https://github.com/carlsonkPhD/tRNA_Charge-Seq/). Gene expression data from prostate cancer patients (PRAD) in the TCGA database used for correlation analysis is publicly available.

The following data sets were generated

Article and author information

Author details

  1. Ricardo A Cordova

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  2. Jagannath Misra

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  3. Parth H Amin

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  4. Anglea J Klunk

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  5. Nur P Damayanti

    Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  6. Kenneth R Carlson

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  7. Andrew J Elmendorf

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  8. Hyeong-Geug Kim

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  9. Emily T Mirek

    Department of Nutritional Sciences, Rutgers, The State University of New Jersey, New Brunswick, United States
    Competing interests
    No competing interests declared.
  10. Bennet D Elzey

    5Department of Comparative Pathology, Purdue University West Lafayette, West Lafayette, United States
    Competing interests
    No competing interests declared.
  11. Marcus J Miller

    Indiana University School of Medicine, Indianapolis, United States
    Competing interests
    No competing interests declared.
  12. X Charlie Dong

    1Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  13. Liang Cheng

    Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, United States
    Competing interests
    No competing interests declared.
  14. Tracy G Anthony

    Department of Nutritional Sciences, Rutgers, The State University of New Jersey, New Brunswick, United States
    Competing interests
    Tracy G Anthony, is a consultant for HiberCell, Inc..
  15. Robero Pili

    Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, United States
    For correspondence
    rpili@buffalo.edu
    Competing interests
    No competing interests declared.
  16. Ronald C Wek

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    For correspondence
    rwek@iu.edu
    Competing interests
    Ronald C Wek, is a member of the advisory board and holds equity in HiberCell, Inc..
  17. Kirk A Staschke

    Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, United States
    For correspondence
    kastasch@iu.edu
    Competing interests
    Kirk A Staschke, is a consultant for HiberCell, Inc. and receives research support from HiberCell, Inc..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8722-9585

Funding

NIH Office of the Director (GM136331)

  • Ronald C Wek

NIH Office of the Director (DK109714)

  • Tracy G Anthony

National Cancer Institute (R21CA221942)

  • Robero Pili

Indiana University Melvin and Bren Simon Comprehensive Cancer Center (P30CA082709)

  • Kirk A Staschke

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at Indiana University School of Medicine (Protocol #21014) and comply with all regulations for ethical conduct of animal research. Human prostate core needle biopsy specimens were obtained from the Indiana University Comprehensive Cancer Center Tissue Procurement and Distribution Core and approval was granted by the Institutional Review Board (IRB #1796) at the Office of Research Administration at Indiana University.

Copyright

© 2022, Cordova et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,886
    views
  • 788
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ricardo A Cordova
  2. Jagannath Misra
  3. Parth H Amin
  4. Anglea J Klunk
  5. Nur P Damayanti
  6. Kenneth R Carlson
  7. Andrew J Elmendorf
  8. Hyeong-Geug Kim
  9. Emily T Mirek
  10. Bennet D Elzey
  11. Marcus J Miller
  12. X Charlie Dong
  13. Liang Cheng
  14. Tracy G Anthony
  15. Robero Pili
  16. Ronald C Wek
  17. Kirk A Staschke
(2022)
GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis
eLife 11:e81083.
https://doi.org/10.7554/eLife.81083

Share this article

https://doi.org/10.7554/eLife.81083

Further reading

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Ashley L Cook, Surojit Sur ... Nicolas Wyhs
    Research Article

    Despite exciting developments in cancer immunotherapy, its broad application is limited by the paucity of targetable antigens on the tumor cell surface. As an intrinsic cellular pathway, nonsense-mediated decay (NMD) conceals neoantigens through the destruction of the RNA products from genes harboring truncating mutations. We developed and conducted a high-throughput screen, based on the ratiometric analysis of transcripts, to identify critical mediators of NMD in human cells. This screen implicated disruption of kinase SMG1’s phosphorylation of UPF1 as a potential disruptor of NMD. This led us to design a novel SMG1 inhibitor, KVS0001, that elevates the expression of transcripts and proteins resulting from human and murine truncating mutations in vitro and murine cells in vivo. Most importantly, KVS0001 concomitantly increased the presentation of immune-targetable human leukocyte antigens (HLA) class I-associated peptides from NMD-downregulated proteins on the surface of human cancer cells. KVS0001 provides new opportunities for studying NMD and the diseases in which NMD plays a role, including cancer and inherited diseases.

    1. Cancer Biology
    Ke Ning, Yuanyuan Xie ... Ling Yu
    Research Article

    For traditional laboratory microscopy observation, the multi-dimensional, real-time, in situ observation of three-dimensional (3D) tumor spheroids has always been the pain point in cell spheroid observation. In this study, we designed a side-view observation petri dish/device that reflects light, enabling in situ observation of the 3D morphology of cell spheroids using conventional inverted laboratory microscopes. We used a 3D-printed handle and frame to support a first-surface mirror, positioning the device within a cell culture petri dish to image cell spheroid samples. The imaging conditions, such as the distance between the mirror and the 3D spheroids, the light source, and the impact of the culture medium, were systematically studied to validate the in situ side-view observation. The results proved that placing the surface mirror adjacent to the spheroids enables non-destructive in situ real-time tracking of tumor spheroid formation, migration, and fusion dynamics. The correlation between spheroid thickness and dark core appearance under light microscopy and the therapeutic effects of chemotherapy doxorubicin and natural killer cells on spheroids’ 3D structure was investigated.